Trends and disparities in lung cancer mortality among older adults with chronic lower respiratory diseases: A nationwide analysis of US data from 1999 to 2020.

A Ahmad Shahid (DOW University of Health Sciences, Karachi, Pakistan) A Ayesha Mubbashir (Dow Medical College, Karachi, Pakistan) U Umar Khan F Fatima Tuz Zahra (1H. Lee Moffitt Cancer Center, Tampa, United States) K Komail Khalid Meer T Taimur Faheem (Dow University of Health Sciences, Karachi, Pakistan) F Fatimah Hoda (Dow University of Health Sciences, Karachi, Pakistan) F Fakhar Latif Y Yusuf Hasan Ali (Dow University of Health Sciences, Karachi, Pakistan) A Arooba Hameed Shaikh (Dow University of Health Sciences, Karachi, Pakistan) H Hamza Imran Z Zain Shaikh (Dow Medical College, Karachi, Pakistan) A Aaima Memon (Dow University of Health Sciences, Karachi, Pakistan) F Fizza Mohsin (Maimonides Medical Center, Brooklyn, New York, United States) U Utsav Joshi (1H. Lee Moffitt Cancer Center, Tampa, United States) A Abdullah Naveed (Dow University of Health Sciences, Karachi, Pakistan) F Fahira Rasheed (Dow University of Health Sciences, Karachi, Pakistan) A Amaan Jamshed Butt (Institute of Business Administration, Karachi, Pakistan) U Uzair Ahmed (Institute of Business Administration, Karachi, Sindh, Pakistan) M Muhammad Saim Siddiqui (Bahria Town School & College, Lahore, Pakistan)

Abstract

e22547 Background: Lung cancer is a leading cause of mortality among older adults with a history of chronic lower respiratory diseases (CLRD). Examining trends and disparities in lung cancer mortality within this population is crucial for informing interventions aimed at improving survival outcomes and quality of life for these patients. Methods: We analyzed data from the Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) database (1999–2020) to assess lung cancer mortality in adults ≥65 with CLRD. Identified UCD ICD-10 codes for lung cancer were: C33, C34, C39.9, C78.0, C78.3, D02.1-D02.4, D14.2-D14.4. ICD-10 codes for CLRD (J40-47) were added as contributing cause. Age-Adjusted Mortality Rates (AAMRs) were calculated per 100,000 and stratified for age, sex, race, and region. Joinpoint Regression (Version 5.1.0, National Cancer Institute) assessed the temporal trends as annual percentage changes (APCs). Results: Nationwide analysis between 1999-2020 shows the AAMRs had a general decline, starting with 50.4 in 1999 and ending with 38.5 in 2020, with a mean APC of -1.44. Males had a higher mean AAMR (58.7) than females (35.6), but saw a greater fall in mortality rates (APC male: -2.25, APC female: -0.75). White individuals had the greatest mean AAMR (50.2). Geographically, Midwestern US had the highest mean AAMR (52.5). Urban-rural AAMR differences were noted as well (Urban: 42.3, Rural: 54.9). Conclusions: Our study reveals a declining trend in lung cancer mortality among elderly CLRD patients, though gender and ethnic disparities persist. Rural areas, particularly in the Midwest, remain at higher risk, highlighting the need for targeted healthcare interventions to improve outcomes. Lung cancer mortality trends in U.S. older adults with CLRD, 1999–2020. Variable AAMR(95% CI) APC(95% CI) Overall 45.2 (45, 45.3) 1999-2007: -0.20* (-0.72, 0.54) 2007-2020: -2.05* (-2.34, -1.83) Women 35.6 (35.4, 35.7) 1999-2007: 1.12* (0.64, 1.76) 2007-2020: -1.59* (-1.84, -1.36) Men 58.7 (58.4, 58.9) 1999-2006: -1.36 (-2.00, 0.48) 2006-2020: -2.59* (-3.13, -2.37) White 50.2 (50, 50.3) 1999-2006: 0.39 (-0.08, 1.04) 2006-2020: -1.70* (-1.89, -1.53) Black/African American 35 (34.6, 35.5) 1999-2020: -1.32* (-1.58, -1.04) American Indian/Alaska Native 44.1 (42.2, 46.1) 1999-2004: 7.62* (0.84, 35.56) 2004-2020: -1.12* (-4.37, -0.11) Hispanic/Latino 15.5 (15.2, 15.8) 1999-2020: -2.31* (-2.63, -1.95) Asian/Pacific Islander 13.9 (13.5, 14.3) 1999-2007: -1.12* (-4.37, -0.11) 2007-2020: -4.22* (-5.67, -3.45) Rural 58.3 (57.9, 58.6) 1999-2004: 2.01* (0.96, 3.72) 2004-2020: -0.98* ( -1.18, -0.80) Urban 42.3 (42.1, 42.4) 1999-2007: -0.51 (-1.06, 0.43) 2007-2020: -2.25* (-2.65, -1.97)

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (20)

A

Ahmad Shahid

DOW University of Health Sciences, Karachi, Pakistan

A

Ayesha Mubbashir

Dow Medical College, Karachi, Pakistan

U

Umar Khan

F

Fatima Tuz Zahra

1H. Lee Moffitt Cancer Center, Tampa, United States

K

Komail Khalid Meer

T

Taimur Faheem

Dow University of Health Sciences, Karachi, Pakistan

F

Fatimah Hoda

Dow University of Health Sciences, Karachi, Pakistan

F

Fakhar Latif

Y

Yusuf Hasan Ali

Dow University of Health Sciences, Karachi, Pakistan

A

Arooba Hameed Shaikh

Dow University of Health Sciences, Karachi, Pakistan

H

Hamza Imran

Z

Zain Shaikh

Dow Medical College, Karachi, Pakistan

A

Aaima Memon

Dow University of Health Sciences, Karachi, Pakistan

F

Fizza Mohsin

Maimonides Medical Center, Brooklyn, New York, United States

U

Utsav Joshi

1H. Lee Moffitt Cancer Center, Tampa, United States

A

Abdullah Naveed

Dow University of Health Sciences, Karachi, Pakistan

F

Fahira Rasheed

Dow University of Health Sciences, Karachi, Pakistan

A

Amaan Jamshed Butt

Institute of Business Administration, Karachi, Pakistan

U

Uzair Ahmed

Institute of Business Administration, Karachi, Sindh, Pakistan

M

Muhammad Saim Siddiqui

Bahria Town School & College, Lahore, Pakistan